Cross Country Healthcare (CCRN) Depreciation & Amortization (CF) (2010 - 2026)

Cross Country Healthcare has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $3.7 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 23.11% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $15.7 million (down 14.4% YoY), and the FY2025 full-year result was $16.8 million, down 7.73% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $3.7 million, down from $3.8 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $4.9 million in Q1 2023, with the low at $2.7 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $4.1 million across 5 years, with a median of $4.3 million in 2024.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 80.36% — and 2026, when it fell 23.11%.
• Cross Country Healthcare's Depreciation & Amortization (CF) stood at $3.2 million in 2022, then soared by 41.4% to $4.5 million in 2023, then fell by 2.91% to $4.3 million in 2024, then declined by 11.7% to $3.8 million in 2025, then dropped by 4.28% to $3.7 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $3.7 million (Q1 2026), $3.8 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.